July 11, 2018 by Chain Drug Review
Albert Bourla, Angela Hwang, biosimilars, Ian Read, John Young, Michael Goettler, Pfizer, Pfizer Consumer Healthcare
Business, Leading Headlines, Supplier News
NEW YORK — Pfizer Inc. announced it will organize the company into three businesses: a science-based Innovative Medicines business which will now include biosimilars and a new hospital business unit for anti-infectives and sterile injectables; an off-patent branded and generic Established Medicines business operating with substantial autonomy within Pfizer and a Consumer Healthcare business. These
March 27, 2018 by Chain Drug Review
consumer health care, Emma Walmsley, GlaxoSmithKline, GSK-Novartis Consumer Healthcare, Novartis, Pfizer Consumer Healthcare, Vas Narasimhan
Business, Leading Headlines, Pharmacy, Supplier News
LONDON and BASEL, Switzerland — GlaxoSmithKline plc plans to buy Novartis’ 36.5% stake in their consumer health care joint venture for $13 billion. Under the agreement announced Tuesday, Novartis’ shares in the joint venture will be canceled, and the joint venture will pay the buyout price to Novartis. GSK has entered into a committed facilities agreement to
October 18, 2017 by Chain Drug Review
AstraZeneca, Aurobindo Pharma, generic version of Nexium 24HR, Nexium 24HR, Pfizer Consumer Healthcare
Pharmacy, Supplier News
HYDERABAD, India — Aurobindo Pharma Ltd. has received Food and Drug Administration approval to manufacture over-the-counter 20-mg esomeprazole magnesium delayed-release capsules, an antacid. Aurobindo said its esomeprazole OTC product, being shipped immediately, is a generic version of Nexium 24HR capsules from Pfizer Consumer Healthcare. A proton pump inhibitor (PPI), Nexium 24HR capsules are indicated for
October 17, 2017 by Chain Drug Review
Mark Gelbert, Nature's Bounty, Paul Sturman, Pfizer Consumer Healthcare
Supplier News
RONKONKOMA, N.Y. — Former Pfizer executive Mark Gelbert has been named chief scientific officer of The Nature’s Bounty Co. Gelbert will lead Nature’s Bounty’s research, development and innovation efforts by creating and executing product development strategies, enhancing product offerings, and driving product advancements across all of its global brands. “I am thrilled to be joining
October 11, 2017 by Chain Drug Review
Albert Bourla, Ian Read, Pfizer, Pfizer Consumer Healthcare, Pfizer Innovative Health
Business, Featured Articles, Leading Headlines, Pharmacy, Supplier News
NEW YORK — Pfizer Inc. is assessing strategic options for its Pfizer Consumer Healthcare subsidiary, including a potential sale. The pharmaceutical giant said this week that it’s considering “a full or partial separation of the Consumer Healthcare business from Pfizer through a spin-off, sale or other transaction.” However, the company noted that it may decided
October 6, 2015 by Chain Drug Review
Bahar Takhtehchian, Centrum, Centrum VitaMints, multivitamin, Pfizer Consumer Healthcare, Robert Uccardi
Supplier News
MADISON, N.J. — Centrum is providing a more flavorful and convenient way to take a multivitamin. The Pfizer Consumer Healthcare brand has launched Centrum VitaMints, a minty, chewable multivitamin. The company said the new multivitamin, which has a cool mint flavor, can be enjoyed like a mint and taken on the go, with or without
July 21, 2015 by Chain Drug Review and Chain Drug Review
Caltrate Bone & Joint Health, Pfizer Consumer Healthcare
Supplier News
MADISON, N.J. — Pfizer Consumer Healthcare has rolled out Caltrate Bone & Joint Health, described as a triple-action supplement to promote bone health. Pfizer said Tuesday that the once-daily Caltrate Bone & Joint Health, now available exclusively at Walgreens, provides three benefits in one supplement: UC-II, an exclusive form of collagen, to support healthy cartilage
May 21, 2015 by Chain Drug Review and Chain Drug Review
Centrum, Centrum MultiGummies, Chris Lynch, multivitamin, Pfizer Consumer Healthcare
Supplier News
MADISON, N.J. — Pfizer Consumer Healthcare has launched Centrum MultiGummies, a multivitamin that comes in an easier-to-take, pleasant-tasting gummy form. Centrum MultiGummies include key nutrients such as vitamins D, B12 and E and come in natural flavors, including berry, cherry and orange. The product also is gluten-free, contains only natural colorants and has no artificial sweeteners. Pfizer said Thursday that Centrum MultiGummies offer a more appealing